MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$19,694
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Revenue
-
-
-
0
General and administrative
14,848
33,025
3,901
14,300
Professional fees
4,846
4,065
4,081
4,081
Total operating expenses
19,694
37,090
7,982
18,381
Loss from operations
-19,694
-37,073
-7,999
-18,381
Loss before provision for income taxes
-19,694
-37,073
-7,999
-18,381
Provision for income taxes
-
-
-
0
Net loss
-19,694
-37,073
-7,999
-18,381
Basic EPS
0
-0
-
0
Diluted EPS
0
-0
0
0
Basic Average Shares
1,051,689,224
1,089,870,671
-
1,026,406,001
Diluted Average Shares
1,051,689,224
1,097,583,894
1,039,836,001
1,026,406,001
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$19,694
(-7.14%↓ Y/Y)
Loss before
provision for income taxes
-$19,694
(-7.14%↓ Y/Y)
Loss from operations
-$19,694
(-7.14%↓ Y/Y)
Total operating
expenses
$19,694
(7.14%↑ Y/Y)
General and
administrative
$14,848
(3.83%↑ Y/Y)
Professional fees
$4,846
(18.75%↑ Y/Y)
Buy us a coffee
NIKA PHARMACEUTICALS, INC (NIKA)
NIKA PHARMACEUTICALS, INC (NIKA)